3-hydroxykynurenine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
3-hydroxykynurenine: RN given refers to cpd without isomeric designation
3-hydroxykynurenine : A hydroxykynurenine that is kynurenine substituted by a hydroxy group at position 3.
hydroxykynurenine : A hydroxy-amino acid that is kynurenine substituted by a single hydroxy group at unspecified position. A "closed" class.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansone, L | 1 |
| Briviba, M | 1 |
| Silamikelis, I | 1 |
| Terentjeva, A | 1 |
| Perkons, I | 1 |
| Birzniece, L | 1 |
| Rovite, V | 1 |
| Rozentale, B | 1 |
| Viksna, L | 1 |
| Kolesova, O | 1 |
| Klavins, K | 1 |
| Klovins, J | 1 |
1 other study available for 3-hydroxykynurenine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis.
Topics: Amino Acids; Biomarkers; COVID-19; Hospitals; Host Microbial Interactions; Humans; Kynurenine; Metab | 2021 |